Calidi Biotherapeutics raises $4.6 million through warrant exercise

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. TMUS
8. VZ
9. SPY
10. UNH

Go back to Calidi Biotherapeutics raises $4.6 million through warrant exercise

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

July 9, 2025 2:01 PM EDT

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (Calidi or the Company) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding Series A, Series B-1, Series C-1, Series D, Series E and Series F Warrants (the Existing Warrants) to purchase up to an aggregate of 6,595,000 shares of the Companys common stock at a reduced exercise price of $0.70. The gross proceeds... More